Chi-Med to Present at Bank of America Merrill Lynch Annual Health Care Conference

LONDON, May 11, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM:HCM) (Nasdaq:HCM) announced today that Christian Hogg, Chief Executive Officer, will present at the Bank of America Merrill Lynch 2018 Health Care Conference on Wednesday, May 16, 2018 at 1:00 pm PDT in Las Vegas.

The presentation and Q&A session will be webcast live and can be accessed at www.chi-med.com in the Shareholder Information section under “Events, Circulars & Forms.” Investors interested in listening to the live webcast should log on before the start time to download any software required. A replay of the event will be available shortly thereafter, for 90 days.

About Chi-Med

Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 1). For more information, please visit: www.chi-med.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. For further discussion of these and other risks, see Chi-Med’s filings with the U.S. Securities and Exchange Commission and on AIM. Chi-Med undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.

CONTACTS        
         
Investor Enquiries        
Mark Lee, Senior Vice President, Corporate Finance & Development   +852 2121 8200    
         
U.K. & International Media Enquiries        
Anthony Carlisle, Citigate Dewe Rogerson   +44 7973 611 888 (Mobile)   anthony.carlisle@cdrconsultancy.co.uk
         
U.S. Based Media Enquiries        
Brad Miles, BMC Communications   +1 (917) 570 7340 (Mobile)   bmiles@bmccommunications.com
Susan Duffy, BMC Communications   +1 (917) 499 8887 (Mobile)   sduffy@bmccommunications.com
         
Investor Relations        
Matt Beck, The Trout Group   +1 (917) 415 1750 (Mobile)   mbeck@troutgroup.com
David Dible, Citigate Dewe Rogerson     +44 7967 566 919 (Mobile)   david.dible@citigatedewerogerson.com
         
Panmure Gordon (UK) Limited        
Richard Gray / Andrew Potts   +44 (20) 7886 2500    

 

Ads